Efficient gene therapy is mainly dependent on the gene transfer capability of gene delivery
vectors. Non-viral vectors have become the research interest of many researchers because …

Recent developments and improvements of multimodal imaging methods for use in animal
research have substantially strengthened the options of in vivo visualization of cancer …

Multifunctional, lipopolyplex formulations comprising a mixture of cationic liposomes and
cationic, receptor-targeting peptides have potential use in gene therapy applications …

Nonviral vectors which offer a safer and versatile alternative to viral vectors have been
developed to overcome problems caused by viral carriers. However, their transfection …

Gadolinium-based nanoscale magnetic resonance imaging (MRI) contrast agents (CAs)
have gained significant momentum as a promising nanoplatform for detecting tumor tissue in …

Lipid‐based nanoparticles have recently shown great promise, establishing themselves as
the gold standard in delivering novel RNA therapeutics. However, research on the effects of …

In recent years, gene therapy has made tremendous progress in the development of disease
treatment. Among them, siRNA offers specificity of gene silencing, ease of synthesis, and …

Most brain diseases such as tumors and neurodegenerative diseases are devastating for
patients with high morbidity and mortality. Gene therapy is a promising strategy for the …

Abstract T 1/T 2 dual-mode magnetic resonance (MR) contrast agents (DMCAs) have gained
much attention because of their ability to improve accuracy by providing two pieces of …

There is increasing evidence that the Myocardin-related transcription factor/Serum response
factor (MRTF/SRF) pathway plays a key role in fibroblast activation and that knocking down …